NeoMab
"NeoMab" is a word mark owned by GemPharmatech Co., Ltd., filed at the CIPO on January 6, 2024. It is registered and covers classes 10, 31 and 42.
- Status
- Registered
- Since July 25, 2025
- Filed
- January 6, 2024
- Registered
- July 25, 2025
- Expires
- July 25, 2035
- Application no.
- 2304089
- Registration no.
- TMA1335232
- Office
- CIPO
- Canadian Intellectual Property Office
- Mark type
- Word mark
- 3 classes
Who owns NeoMab
The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.
Owner
GemPharmatech Co., Ltd.
China
Representative
Neomark Ltd.
Neomark Ltd.
What the mark covers
The products and services NeoMab is filed for, grouped by Nice class.
Containers especially made for medical waste; droppers for medical purposes; gene testing medical apparatus for identification of genus specific and species specific DNA and RNA sequences; hypodermic syringes; implantable subcutaneous drug delivery devices; instrument cases for use by doctors; insufflators; medical apparatus and instruments for amplifying nucleic acid DNA and RNA molecules; syringes for injections; syringes for medical purposes; veterinary instruments
Bran mash for animal consumption; edible chews for animals; flaxseed meal for animal consumption; foodstuffs for pets; fresh fruit; fresh garden herbs; linseed meal for animal consumption; litter for animals; live laboratory animals; live poultry; live shrimp; mushroom spawn for propagation; rapeseed meal for animal consumption; soy bean meal for animal consumption; unprocessed seaweed for human or animal consumption
Chemical research; culturing of cells for scientific research purposes; genetic testing for scientific research purposes; laboratory research analysis in the field of genetic testing; laboratory research in the field of immune sequencing; medical research; preparation of biological samples for testing and analysis in research laboratories; research and development of new products for others; scientific research in the field of genetics; scientific research in the field of immune sequencing; scientific research in the field of pharmacology, pharmaceuticals, and biochemistry; scientific research laboratories for conducting research in the field of cancer, cancer prevention and cancer diagnosis; scientific research services in the field of cell therapy; scientific research services in the field of gene therapy
What has happened so far
Steps recorded by the CIPO, newest first.
- Registered
- Registration Pending
- Advertised; Vol.72 Issue 3680
- Approval Notice Sent; APPROVED BY PROGRAM EX200M1
- Approved; APPROVED BY PROGRAM EX200M1
- Search Recorded
- Formalized
- Created
- Filed
About NeoMab
Who owns the trademark "NeoMab"?
The CIPO trademark "NeoMab" (application 2304089) is owned by GemPharmatech Co., Ltd.
What is the status of "NeoMab"?
Its status at the CIPO is: registered.
When was "NeoMab" registered?
It was registered on July 25, 2025 and is due to expire on July 25, 2035.
Get this data via the API
Everything on this page comes from the Signa API. Pull NeoMab and marks like it into your own product with one request.
GET/v1/trademarks/{id}The full record: owners, classes, dates and images
GET/v1/trademarks/{id}/eventsEvery step in the office history
GET/v1/proceedings?trademark_id={id}Oppositions and cancellations against the mark
ID=tm_019deb40-05cd-718c-b70e-a71bd873d6c9
curl https://api.signa.so/v1/trademarks/$ID \
-H "Authorization: Bearer $SIGNA_API_KEY"{
"id": "tm_019deb40-05cd-718c-b70e-a71bd873d6c9",
"object": "trademark",
"mark_text": "NeoMab",
"status": {
"primary": "active",
"stage": "registered"
},
"office_code": "CA",
"application_number": "2304089",
"filing_date": "2024-01-06",
"nice_classes": [
10,
31,
42
],
"owners": [
{
"name": "GemPharmatech Co., Ltd.",
"entity_id": "ent_019eb7dd-5b13-70cd-880d-9b7bc5be78fb"
}
]
}